Qualcomm funds study of bloodstream sensors, app-enabled genetic tests | mobihealthnews | Longevity science | Scoop.it

The Qualcomm Foundation announced this week that it had awarded the Scripps Translational Science Institute (STSI) $3.75 million to fund clinical trials focused on wireless biosensor systems, rapid pharmacogenomic diagnostic tests, and apps and embedded sensors for tracking and predicting heart attacks, Type 1 diabetes and some types of cancer. The monies will help fund three years of research focused on wireless health.